Breaking News Instant updates and real-time market news.

SMMT

Summit Therapeutics

$12.87

-0.04 (-0.31%)

04:55
06/13/18
06/13
04:55
06/13/18
04:55

Summit Therapeutics management to meet with Oppenheimer

Meetings to be held in Europe June 12-13 hosted by Oppenheimer.

  • 13

    Jun

SMMT Summit Therapeutics
$12.87

-0.04 (-0.31%)

03/28/18
JMPS
03/28/18
NO CHANGE
Target $42
JMPS
Outperform
FDA guidance to Sarepta could speed Summit's DMD path, says JMP Securities
JMP Securities analyst Liisa Bayko noted that the FDA recently communicated to Sarepta Therapeutics (SRPT) that it would allow a statistically significant increase in de novo truncated dystrophin to serve as the basis for accelerated approval for golodirsen. She thinks this could also open the door for Summit Therapeutics (SMMT) to utilize utrophin as a potential biomarker for accelerated approval of ezutromid, its own Duchenne muscular dystrophy candidate, adding that she sees an accelerated path as upside to her valuation. Bayko keeps an Outperform rating and $42 price target on Summit shares.
04/12/18
NEED
04/12/18
NO CHANGE
Target $27
NEED
Buy
Summit Therapeutics price target lowered to $27 at Needham on equity dilution
Needham analyst Chad Messer lowered his price target on Summit Therapeutics to $27 from $30, citing the impact of the recently announced GBP15M equity raise. The analyst keeps his Buy rating on stock, noting he remains positive on Summit Therapeutics after its Phase 2 readout of the PhaseOut DMD study of ezutromid as the 24-week data "demonstrated a clear sign of drug efficacy" while de-risking the program "meaningfully".
04/12/18
BTIG
04/12/18
NO CHANGE
Target $33
BTIG
Buy
Summit Therapeutics positioned for more upside, says BTIG
BTIG analyst Timothy Chung keeps his Buy rating and $33 price target on Summit Therapeutics after its FY18 results, saying the company is well positioned for upside as it continues to expect the release of top-line results from its Phase 2 PhaseOut study of ezutromid in Q3. Having already shown some positive results in the 24-week data, the analyst contends there's a good chance of a successful outcome for the program which may lead to approval by 2020 - a year sooner than he previously expected.
05/02/18
JANY
05/02/18
INITIATION
Target $27
JANY
Buy
Summit Therapeutics initiated with a Buy at Janney Capital
Janney Capital analyst Yun Zhong started Summit Therapeutics with a Buy rating and $27 fair value estimate, calling the efficacy data for ezutromid underappreciated. Zhong expects the 48-week data to be reported in Q3 to demonstrate maintained or improved treatment effect and "conservatively" models an FDA approval in 2021.

TODAY'S FREE FLY STORIES

VIPS

Vipshop

$5.54

0.07 (1.28%)

13:50
11/21/18
11/21
13:50
11/21/18
13:50
Options
Aggressive call buy in Vipshop »

Aggressive call buy in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

13:50
11/21/18
11/21
13:50
11/21/18
13:50
General news
Treasury Action: yields remain only marginally firmer »

Treasury Action: yields…

PFE

Pfizer

$43.23

-0.3 (-0.69%)

13:41
11/21/18
11/21
13:41
11/21/18
13:41
Hot Stocks
Pfizer says FDA approves DAURISMO for adults with newly-diagnosed AML »

Pfizer announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 03

    Dec

  • 10

    Dec

EFA

iShares MSCI EAFE Index Fund

$62.35

1.05 (1.71%)

13:40
11/21/18
11/21
13:40
11/21/18
13:40
Options
Call buying in iShares Emerging Markets Fund and iShares MSCI EAFA Fund »

Call buying in iShares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

13:30
11/21/18
11/21
13:30
11/21/18
13:30
Options
Vix calls lead puts 4:1 as the index drops 9% »

Vix calls lead puts 4:1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKRX

Akorn

$6.95

0.18 (2.66%)

13:25
11/21/18
11/21
13:25
11/21/18
13:25
Options
Akorn call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

OMED

OncoMed

$1.37

(0.00%)

13:22
11/21/18
11/21
13:22
11/21/18
13:22
Hot Stocks
OncoMed awarded European patent for method for making heteromultimeric molecules 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQST

Aquestive Therapeutics

$10.12

-3.05 (-23.16%)

, RDY

Dr. Reddy's

$36.37

-0.11 (-0.30%)

13:17
11/21/18
11/21
13:17
11/21/18
13:17
Hot Stocks
Aquestive under pressure after generic Suboxone patent decision »

Shares of Aquestive…

AQST

Aquestive Therapeutics

$10.12

-3.05 (-23.16%)

RDY

Dr. Reddy's

$36.37

-0.11 (-0.30%)

MYL

Mylan

$33.29

-0.65 (-1.92%)

ENDP

Endo

$12.39

-0.14 (-1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 02

    Dec

  • 04

    Dec

  • 19

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/21/18
11/21
13:17
11/21/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/21/18
11/21
13:16
11/21/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$12.60

0.3 (2.44%)

, T

AT&T

$30.01

0.6 (2.04%)

13:15
11/21/18
11/21
13:15
11/21/18
13:15
Hot Stocks
GameStop jumps over 10% after agreeing to sell Spring Mobile unit »

Shares of GameStop (GME)…

GME

GameStop

$12.60

0.3 (2.44%)

T

AT&T

$30.01

0.6 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 29

    Nov

  • 29

    Nov

  • 03

    Dec

MDT

Medtronic

$93.03

0.72 (0.78%)

13:11
11/21/18
11/21
13:11
11/21/18
13:11
Hot Stocks
Medtronic to acquire Nutrino Health, terms not disclosed »

Medtronic announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

13:10
11/21/18
11/21
13:10
11/21/18
13:10
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

13:07
11/21/18
11/21
13:07
11/21/18
13:07
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 11/21…

GME

GameStop

$12.60

0.3 (2.44%)

13:06
11/21/18
11/21
13:06
11/21/18
13:06
Hot Stocks
Breaking Hot Stocks news story on GameStop 

GameStop trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

BHGE

Baker Hughes

$22.68

0.27 (1.20%)

13:04
11/21/18
11/21
13:04
11/21/18
13:04
Hot Stocks
Baker Hughes reports U.S. rig count down 3 to 1,079 rigs »

Baker Hughes reports the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

VLKAY

Volkswagen

$0.00

(0.00%)

, AVGO

Broadcom

$232.01

4.32 (1.90%)

13:04
11/21/18
11/21
13:04
11/21/18
13:04
Periodicals
Broadcom agrees to settle patent lawsuit against Volkswagen, Reuters says »

Volkswagen (VLKAY) has…

VLKAY

Volkswagen

$0.00

(0.00%)

AVGO

Broadcom

$232.01

4.32 (1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ESV

Ensco

$6.62

0.43 (6.95%)

13:00
11/21/18
11/21
13:00
11/21/18
13:00
Options
Aggressive call buying in Ensco as shares gain 6.3% »

Aggressive call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELLI

Ellie Mae

$65.08

1.4 (2.20%)

12:54
11/21/18
11/21
12:54
11/21/18
12:54
Hot Stocks
Breaking Hot Stocks news story on Ellie Mae »

HMI Capital reports 5.67%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

GME

GameStop

$12.60

0.3 (2.44%)

12:50
11/21/18
11/21
12:50
11/21/18
12:50
Hot Stocks
GameStop says board still reviewing strategic, financial alternatives »

"This transaction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

GME

GameStop

$12.60

0.3 (2.44%)

12:49
11/21/18
11/21
12:49
11/21/18
12:49
Hot Stocks
GameStop to sell Spring Mobile unit to Prime Communications for $700M »

GameStop (GME) announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

12:45
11/21/18
11/21
12:45
11/21/18
12:45
General news
Breaking General news story  »

Week of 11/21…

GME

GameStop

$12.60

0.3 (2.44%)

12:44
11/21/18
11/21
12:44
11/21/18
12:44
Hot Stocks
Breaking Hot Stocks news story on GameStop »

GameStop trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

OMC

Omnicom

$76.77

1.06 (1.40%)

, WPP

WPP

$54.99

1.4 (2.61%)

12:42
11/21/18
11/21
12:42
11/21/18
12:42
Hot Stocks
Omnicom rises after winning $4B U.S. Army ad account »

Shares of Omnicom (OMC)…

OMC

Omnicom

$76.77

1.06 (1.40%)

WPP

WPP

$54.99

1.4 (2.61%)

F

Ford

$9.16

0.1 (1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 13

    Dec

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

RHT

Red Hat

$173.28

-0.22 (-0.13%)

, IBM

IBM

$118.90

1.73 (1.48%)

12:41
11/21/18
11/21
12:41
11/21/18
12:41
Periodicals
EC review of Red Hat-IBM deal to 'zoom in' on middleware, Dealreporter says »

The European Commission…

RHT

Red Hat

$173.28

-0.22 (-0.13%)

IBM

IBM

$118.90

1.73 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 05

    Dec

  • 06

    Dec

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.